Listed

Akso Health Group: Form 20-F for the period ended Mar 31, 2023

Filed with the SEC on Jul 14, 2023 and accepted by EDGAR at Jul 14, 2023, 16:30 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2022-04-01 to 2023-03-31$13.2mus-gaap:Revenues
Gross profit12 months2022-04-01 to 2023-03-31$1.3mus-gaap:GrossProfit
Operating income12 months2022-04-01 to 2023-03-31−$14.3mus-gaap:OperatingIncomeLoss
Income tax12 months2022-04-01 to 2023-03-31$17.5kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2022-04-01 to 2023-03-31−$1.4mus-gaap:NetIncomeLoss
Diluted EPS12 months2022-04-01 to 2023-03-31−$0.02us-gaap:EarningsPerShareDiluted
Basic EPS12 months2022-04-01 to 2023-03-31−$0.02us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2022-04-01 to 2023-03-3168,598,050 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2022-04-01 to 2023-03-31−$3.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2023-03-31$7.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-03-31$20.5mus-gaap:AssetsCurrent
Total assetsAt period end2023-03-31$20.5mus-gaap:Assets
Current liabilitiesAt period end2023-03-31$11.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-03-31$11.6mus-gaap:Liabilities
Shareholders' equityAt period end2023-03-31$8.7mus-gaap:StockholdersEquity
Shares outstandingAt period end2023-03-3168,598,050 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001213900-23-057106. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.